Page last updated: 2024-10-24

candesartan and Movement Disorders

candesartan has been researched along with Movement Disorders in 2 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thakur, KS1
Prakash, A1
Bisht, R1
Bansal, PK1
Gaur, V1
Kumar, A1

Other Studies

2 other studies available for candesartan and Movement Disorders

ArticleYear
Beneficial effect of candesartan and lisinopril against haloperidol-induced tardive dyskinesia in rat.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2015, Volume: 16, Issue:4

    Topics: Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Body Weight; Grooming; Haloperidol; Hand

2015
Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction.
    Inflammopharmacology, 2011, Volume: 19, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Atorvastatin; Behavior, Animal; Benzimidazoles; Bi

2011